Ivermectin ‘does not prevent severe COVID-19’: Study The drug’s use on mild-to-moderate COVID-19 patients does not stop disease progression, a newly published clinical trial suggests.
Controversial Alzheimer’s drug under TGA review ‘should not be approved’ Patients will be put at risk and taxpayers will face a significant economic burden if aducanumab receives regulatory approval, experts say.
Boosters’ Omicron impact outlined in vaccination tool update GPs and patients can now generate personalised information on the risks and benefits associated with choosing whether or not to receive a booster shot.
Study links mental disorders early in life to dementia Mental health disorders are often an underappreciated category of modifiable risk factors for dementia, new research suggests.
Australia the first to approve Moderna vaccine in young children Kids aged 6–11 will soon be able to receive the Moderna Spikevax COVID vaccine, after it received provisional approval for use in this cohort.
Opioids ease osteoarthritis pain only slightly: Research Their deadly risks need to be weighed against any benefit, according to the authors of a new Australian study.
Study finds statin intolerance overestimated and overdiagnosed Fewer than 10% of patients prescribed cholesterol-lowering drugs experience side effects, according to the world’s largest study on statin intolerance.
Vaccine safety anxiety driving parents towards misinformation How can GPs help combat this trend and ensure these patients don’t fall victim to misinformation?
New interactive patient guide for managing COVID at home The online tool expands on existing RACGP advice, giving low-risk patients a clear and accessible framework to manage their own recovery.
RACGP urges action on NT COVID-19 spread Hospitalisations are rising in the territory, with doctors concerned about complacency and the knock-on effects for primary care.